<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol</article-title>
</title-group>
